Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 3, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 5, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001638643-26-000008
Filed / recorded
Feb 5, 2026, 11:46 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
GILEAD SCIENCES, INC.
Issuer CIK
882095
Ticker
GILD
Reporting person
Daniel Patrick O'day
Relationship
Director, Officer
Officer title
Chairman & CEO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 3, 2026
Transaction code
A
Shares / units
131,675
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
688,373
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met.
